Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial. [electronic resource]
Producer: 20010705Description: 2994-3009 p. digitalISSN:- 0732-183X
- Antineoplastic Agents -- therapeutic use
- Bone Marrow -- pathology
- Decision Trees
- Female
- Humans
- Hydroxyurea -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Leukemia, Myeloid, Chronic-Phase -- classification
- Lymphocyte Activation
- Macrophages -- pathology
- Male
- Megakaryocytes -- pathology
- Middle Aged
- Multivariate Analysis
- Primary Myelofibrosis -- pathology
- Prognosis
- Recombinant Proteins
- Regression Analysis
- Reproducibility of Results
- Risk
- Sensitivity and Specificity
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.